Page results
-
Photographs captured during the Black History Month screening on 24th October 2024.
-
Dr Hotton is a consultant neurologist with a special interest in movement disorders and the neurological care of patients with central nervous system tumours.
-
Following the successful premiere at Everyman Cinema, Muswell Hill, SICKLE, the groundbreaking documentary on sickle cell disorder, continued its impactful journey with a screening at Ritzy Picture House in Brixton on Thursday 24 October. Held in celebration of Black History Month, the event aimed to raise awareness and educate both healthcare professionals and the public about the realities of living with sickle cell disorder.
-
The National Hospital for Neurology and Neurosurgery’s Professor Tabrizi is amongst a small number of exceptional researchers from across the world elected to the Fellowship of the Royal Society today.
-
As part of Our National Health Stories, University College London Hospitals NHS Foundation Trust commissioned five poets to write and share stories from the NHS.
-
More than 400 patients at UCLH have so far benefited from an exciting new cancer treatment called proton beam therapy (PBT) – which uses high-energy beams of protons, rather than X-rays, to deliver a dose of radiotherapy.
-
The earliest brain changes due to Huntington’s disease can be detected 24 years before clinical symptoms show, according to a new UCL-led study.
-
UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work for two years running.
-
Details of the charity and voluntary sector services.
-
Details of the charity and voluntary sector services in Islington and surrounding areas.
File results
-
FOI/2023/0292 - Spend on bank/ agency/ locum staff for junior doctor strike cover
-
FOI/2023/0299 - Trust Medical Examiner contact details
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022
-
FOI/2023/0340 - NHS charging of overseas visitors
-
FOI/2023/0341 - Senior staff contact details